Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Synthetic Biologics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 103,089 3.16M 0 0 0
Cost of Goods Sold (COGS) incl. D&A 382,089 467,623 144,000 63,000 43,000
COGS excluding D&A 0 108,915 0 0 0
Depreciation & Amortization Expense 382,089 358,708 144,000 63,000 43,000
Depreciation 382,089 358,708 144,000 63,000 43,000
Amortization of Intangibles 0 0 0 0 0
Gross Income (279,000) 2.7M (144,000) (63,000) (43,000)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.4M 4.28M 3.69M 17.24M 12.3M
Research & Development 1.2M 1.58M 1.64M 12.29M 6.51M
Other SG&A 2.2M 2.7M 2.05M 4.95M 5.79M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 120,747 3.83M 0 0
EBIT after Unusual Expense 0 (120,747) (3.83M) 0 0
Non Operating Income/Expense (43,011) 3,236 22,000 (18,000) (12,000)
Non-Operating Interest Income 2,965 413 14,000 33,000 33,000
Equity in Affiliates (Pretax) - - - - 0
Interest Expense 9,879 10,108 0 0 0
Gross Interest Expense 9,879 10,108 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (3.73M) (1.71M) (7.63M) (17.28M) (12.32M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (3.73M) (1.71M) (7.63M) (17.28M) (12.32M)
Minority Interest Expense 0 0 0 0 (1,000)
Net Income (3.73M) (1.71M) (7.63M) (17.28M) (12.32M)
Extraordinaries & Discontinued Operations 0 0 (523,000) 216,000 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 677,000 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 (523,000) (461,000) 0
Net Income After Extraordinaries (3.73M) (1.71M) (8.15M) (17.07M) (12.32M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (3.73M) (1.71M) (7.63M) (17.28M) (12.32M)
EPS (Basic) (0.18) (0.08) (0.29) (0.51) (0.27)
Basic Shares Outstanding 21.32M 22.39M 27.71M 34.9M 45.67M
EPS (Diluted) (0.18) (0.08) (0.29) (0.51) (0.27)
Diluted Shares Outstanding 21.32M 22.39M 27.71M 34.9M 45.67M
EBITDA (3.3M) (1.23M) (3.69M) (17.24M) (12.3M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.